Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AxoGen Inc (NASDAQ:AXGN)

8.86
Delayed Data
As of Sep 23
 -0.33 / -3.59%
Today’s Change
3.83
Today|||52-Week Range
9.88
+77.20%
Year-to-Date
Teva Presents Top-Line Data from Huntington Disease Study
Sep 20 / Zacks.com - Paid Partner Content
2 Biotech Stocks that Turned $8,000 into over $250,000
Sep 12 / MotleyFool.com - Paid Partner Content
Allergan to Buy Vitae Pharma to Boost Dermatology Suite
Sep 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close9.19
Today’s open9.19
Day’s range8.83 - 9.19
Volume48,623
Average volume (3 months)210,890
Market cap$267.0M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+48.97%
Earnings growth (this year)+22.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+62.52%
P/E ratioNM
Price/Sales4.77
Price/Book32.42

Competitors

 Today’s
change
Today’s
% change
CUTRCutera Inc-0.25-2.04%
ENTLEntellus Medical Inc-0.30-1.46%
IRIXIRIDEX Corp-0.39-2.58%
FONRFonar Corp-0.61-2.92%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$27.3M
Annual profit (last year)-$13.4M
Net profit margin-48.87%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Karen L. Zaderej
Operations Director
Mike Donovan
Corporate headquarters
Alachua, Florida

Forecasts

Search for Jobs